Quality of Life and Health Profile in Individuals with Parkinson’s – Systematic Review

Abstract

Introduction: The latest research on quality of life in Parkinson's patients has emphasized the importance of a comprehensive approach to the care of these individuals. In addition to motor symptoms, non-motor aspects such as sleep disorders, depression, anxiety, cognitive changes and communication difficulties play a crucial role in the general health and well-being of these patients. Objective: Analyze and synthesize the available evidence on the quality of life and health profile in individuals diagnosed with Parkinson's disease. Methods: This study constitutes a systematic review, classified as exploratory and descriptive. The preparation of the research was a bibliographical search in electronic databases on methods associated with RSL (Systematic Literature Review) and the applications of SMARTER (Simple Multi-Attribute Rating Technique using Exploiting Rankings). The study methodology is a systematic, exploratory and descriptive review, using qualitative and quantitative methods. The bibliographic search covered several databases, with well-defined inclusion and exclusion criteria. Data analysis was conducted by three independent researchers. Results and discussion: The results revealed 1659 articles, 18 of which were included in the review. The discussion of the findings of the current article can be enriched by a comprehensive analysis of the existing literature that explores various facets of quality of life (QoL) in individuals with Parkinson's disease (PD). Several studies have investigated different dimensions, providing insights into the factors that influence QoL in PD patients. Conclusion: The findings gathered emphasize the importance of a comprehensive and personalized approach in the treatment of PD, considering not only motor symptoms, but also psychosocial and nutritional aspects and the external context. This integrated approach can serve as a basis for developing more effective strategies to improve QoL in individuals with PD and provide more comprehensive and adaptable support throughout the course of the disease.